Inflammatory Bowel Disease (IBODI)

INFECTION, IMMUNITY AND ENVIRONMENT
TARGETS

Our objective is to understand the pathophysiology of inflammatory bowel disease and to identify new therapeutic strategies for inflammatory bowel diseases such as Crohn’s disease or Ulcerative Colitis, along with complications derived from these diseases such as perianal fistules. Our group combines basic science with clinical studies for translational research with the aim of improving the quality of life of patients.

RESPONSIBLE
  • Dra. Carolina Serena Perelló

Inflammatory bowel disease (IMI), including Crohn’s disease and ulcerative colitis, is characterized by recurrent chronic intestinal inflammation. While the etiology of IIM persists to a great extent unknown, it implies a complex interaction between genetic, environmental or microbial factors and immune responses. A more in-depth knowledge of the pathophysiology of IIM may help to identify our therapeutic approaches to cure these maladies. Our group is especially interested in the relationship between the intestinal microbiota, the immunology and the mare adipose cells. The work in progress points out that the perilesional greix contributes to Crohn’s disease, and the translocation of intestinal bacteria that affect the perilesional greix and the interaction of the mare adipose cells and cells of the immune system in these maladies, ens allows to identify useful biomarkers for the diagnosis, prognosis or progression of malaltia.

  • Multi-omnic approach to the search for early predictive biomarkers of response to biological agents in Crohn’s disease.
  • Role of visceral fat in the pathophysiology of inflammatory bowel diseases.
  • New insights into the therapeutic aspect of adipose stem cells: implications for future stem cell therapies in inflammatory bowel disease.
  • Interaction between cellular and molecular mechanisms underlying the development of inflammatory bowel diseases.
  • Host-microbiome interactions: molecular mechanisms in inflammatory bowel diseases.

  • Títol del projecte: Ensayo clínico en Fase IIa para evaluar seguridad y eficacia del tratamiento con células troncales alogénicas mesenquimales derivadas de la grasa en pacientes con estenosis inflamatoria en el contexto de la Enfermedad de Crohn.

    IP: Loles Herreros Marcos

    Membre de l’equip: Carolina Serena

    Agència financiadora: ISCIII (Proyecto de Investigación Clínica Independiente)

    Financiació: 414.172 €.

    Duració (període de financiació): 01/01/2022-31/12/2024

    Expedient projecte: ICI21/0003

  • Títol del projecte: Succinato, un metabolito derivado de la microbiota, marcador de actividad en la Enfermedad de Crohn.

    IP: Margarita Menacho. Co-IP: Carolina Serena.

    Membres de l’equip: Diandra Monfort, Alicia Moliné, Gemma Valldosera.

    Agència financiadora I Beca Clínica GETECCU-Galápagos

    Financiació: 12.000€

    Duració (període de financiació): 01/01/2022-31/12/2022

    Expedient projecte: I Beca Clínica GETECCU-Galápagos

  • Títol del projecte: Peri-lesional adipose tissue (creeping fat) as an immune modulating element of intestinal dysbiosis in Crohn’s disease

    IP: Carolina Serena

    Membres de l’equip: Margarita Menacho, Aleidis Caro, Beatriz Espina.

    Agència financiadora ISCIII

    Financiació: 185.130 €.

    Duració (període de financiació): 01/01/2019-31/12/2022

    Expedient projecte: PI18/00037 (Proyectos de I+D+I en Salud)

  • Títol del projecte internacional: An integrative analysis of DNA methylation and RNA-Seq data in human adipose-stem cells of Crohn’s disease patients with different clinical activity

    IP: Carolina Serena.

    Membre de l’equip: Margarita Menacho

    Agència financiadora: European Crohn’s and Colitis Organization (ECCO).

    Financiació: 50.000 €.

    Duració (període de financiació): 01/01/2019-30/06/2020

    Expedient projecte: ECCO grant 2018 a Carolina Serena

    URL: https://www.ecco-ibd.eu/publications/ecco-news/committee-news/item/ecco-grant-study-synopsis-carolina-serena.html

  • Títol del projecte: A new probiotic strategy to improve metabolic and inflammatory profile in obese patients. SUCCIPRO.

    IP: Isabel Huber

    Membre de l’equip: Carolina Serena

    Agència financiadora Caixaimpulse. Fundación la Caixa.

    Financiació: 70.000 €.

    Duració (període de financiació): 01/01/2019-31/12/2021

    Expedient projecte: SUCCIPRO

  • Títol del projecte: Analyses of the global kinase activities in adipose tissue to find molecular differences resulting from insulin resistance across different clinical phenotypes from lean to obese and type 2 diabetic patients.

    IP: Joan Vendrell / Luis Fajas

    Membre de l’equip: Carolina Serena

    Agència financiadora: La Marató de TV3

    Financiació: 600.000 €.

    Duració (període de financiació): 01/01/2017-01/01/2020

    Expedient projecte: PV17013S

  • Títol del projecte: Mechanistic basis for the distinct inflammatory profile in obese and CD subjects: searching for novel therapeutic approaches

    IP: Carolina Serena.

    Membre de l’equip: Margarita Menacho

    Agència financiadora ISCIII

    Financiació: 159.000 €.

    Duració (període de financiació): 01/01/2016-30/06/2019

    Expedient projecte: PI15/00143 (Proyectos de I+D+I en Salud)

  • Títol del projecte: Antioxidant compounds in inflammation-related metabolic human diseases: in vitro and in vivo.

    IP: Carolina Serena.

    Agència financiadora MINECO

    Financiació: 40.000 €.

    Duració (període de financiació): 23/10/2014-23/10/2018

    Expedient projecte: RYC-2013-13186 (projecte associat al contrate Ramón y Cajal)

  • Títol del projecte: Identification of novel modulators of chronic inflammation in prevalent diseases: unveiling divergent mechanisms of disease (INFLAMES).

    IP: Antonio Zorzano / Joan Vendrell

    Membre de l’equip: Carolina Serena

    Agència financiadora ISCIII

    Financiació: 480.000 €.

    Duració (període de financiació): 01/01/2015-01/01/2018

    Expedient projecte: PIE14/00145 (Proyectos interciber)

  • Propietat industrial i intel·lectual

    Títol: ColonApp_TGN

    Application date: 14/09/2023

    Ref. i-DEPOT Benellux Office: 143375

    Institution: IISPV (HJ23) i GIPSS

    Inventors: Caro, Aleidis; Lahoz, Mari Carmen; Ayala, David

    Modalitat: software

  • S Fernández-Veledo; C Serena; J Vendrell; V Ceperuelo; E Calvo. PCT/EP2019/051157. Targeted interventions directed at reducing the levels of circulating succinate in a subject, and kits and method for determining effectiveness of said interventions. 17/01/2019. IISPV. WO/2019/141780

  • S Fernández-Veledo; C Serena; J Vendrell; A Zorzano. EP17382615.7. Methods for improving the cell therapy efficacy with mesenchymal stem cell populations. 18/09/2017. CIBERDEM.

    Smoking suppresses the therapeutic potential of adipose stem cells in Crohn's disease patients through epigenetic changes. Cells.

    Boronat A, Vaño I, Monfort D, Menacho M, Valldosera G, Caro A, Espina B, Mañas MJ, Martí M, Espín E, Saera A, Serena C.

    2023. 12. (7):1021.

    Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study). Ann Oncol.
    Randomised clinical trial to test the phenolization in sacrococcygeal pilonidal disease. Int Wound J.
    Micro-elimination of chronic hepatitis C virus in patients with psychiatric disorders: a multidisciplinary strategy in the outpatient mental health center. J. Hepatol.
    Effectiveness of a direct care action strategy at the drug addiction center (test and treat in point of care) for the detection and treatment of hepatitis C in drug users on opioid agonist substitution therapy. J. Hepatol.
    Smoking Suppresses the Therapeutic Potential of Adipose Stem Cells in Crohn’s Disease Patients through Epigenetic Changes

Team Members

  • Group leader

    • Dra. Carolina Serena Perelló
  • Research group

    • Albert Boronat
    • Aleidis Caro
    • Alicia Moliné
    • Beatriz Espina
    • Carme Abadia
    • Diandra Monfort
    • Gemma Valldosera
    • Irene Vaño
    • Jc Quer
    • Lidia Cabrinety
    • Margarita Menacho
    • M. José Mañas
    • Nicolás Moreno